BioSpace News Archive

Encouraging Initial Safety and Compelling Early Efficacy Data Presented at TCT 2018

LUM-201 is an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland

otal knee replacement patients and their surgeons were more satisfied with the cosmetic results and less worried about after care and possible infections when the DERMABOND PRINEO Skin Closure System was used to close the knee’s surgical incision rather than traditional skin staples, according to a new quantitative research study conducted by Ethicon,

Q BioMed Inc. (OTCQB: QBIO), is pleased to announce that it has entered into a definitive agreement with Yorkville Advisors Global (‘Yorkville’) for $4,000,000.

This portfolio expansion demonstrates the Company’s strategic efforts to deliver the most differentiated biologics portfolio in the spine industry.

Today, His Excellency Jakaya Kikwete, former President of Tanzania, and The Access Challenge, a leading not-for-profit advocacy organization focused on universal access to health care, will host a Universal Health Coverage (UHC) High Level Conference and Awards Dinner 2018 at the Westin Times Square in New York City.

Trelegy Ellipta is the triple combination therapy of FF/UMEC/VI in a single ELLIPTA® inhaler.

Ms. Auld is leaving to pursue another opportunity.

Platinum-level sponsor is showcasing its Enhanced Benefit Management and on-demand solutions, sponsoring opening-night reception

Applications are now being accepted for the fourth annual Northrop Grumman Foundation Teachers Academy.